CXCL1 and colitis: In animal models of ETBF-induced tumorigenesis, the BFT was shown to exacerbate colitis in tumorigenesis by promoting the production of the inflammatory cytokine interleukin-17A (IL-17A) and CXCL1 [21,22,23] in the host.